Return to homepagePandemic Pact

Novel drug modalities blocking SARS-CoV-2 infection

Grant number: 2020-03156

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $475,338.16

  • Funder

    Vinnova

  • Principal Investigator

    N/A

  • Research Location

    Sweden

  • Lead Research Institution

    Chalmers University of Technology

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Purpose and goal The project aim is to apply a new drug discovery platform using directed evolution for finding potent peptides targeting the SARS-CoV2 infection. Expected results and effects The project will enable the discovery of new potent peptides targeting SARS-CoV2 infection and will establish a new drug discovery pipeline to find anti-viral peptides. Planned approach and implementation The project is structured according to specific work packages including development of respective synthetic biology tools, conducting of high throughput screening, analysis of the created data sets and hit evaluation.